Observational studyNeurosurgical review2025
Geographical accessibility and case loads in subarachnoid hemorrhage care: a nationwide study of German hospitals.
Observational study in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Simulation of the Effects of Minimum Case Volume Thresholds on the Geographic Accessibility of Inpatient Neurosurgical Facilities in Germany.Healthcare (Basel, Switzerland) · 2026Article
- Access to Neurosurgery for Patients in Germany-Strategic Considerations Based on Geographic Information Mapping.Clinics and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This observational cross-sectional study aims to investigate the accessibility of German hospitals in the event of an aneurysmal subarachnoid hemorrhage (SAH). Specifically, it analyzes the average travel time to hospitals of varying care levels (level 2 = advanced, level 3 = comprehensive), defined as facilities equipped with neurosurgical and/or neurointerventional treatment capacities essential for SAH management, and examines the role of university hospitals in SAH management. Furthermore, the association between accessibility and socioeconomic deprivation will be evaluated. Data from all German hospital cases in 2022 were analyzed, based on Section 136b of the Social Code Book V as outlined by the G-BA. Hospital infrastructure and accessibility metrics were sourced from the trinovis VISION platform (trinovis GmbH, Hannover, Germany) using the tools "hospitals" and "accessibility". A total of 7,855 SAH cases were treated in 794 hospitals across Germany. Among these, 27.3% of hospitals provided extended emergency care (treating 1,249 cases), and 19.6% offered comprehensive care (treating 4,279 cases). In total, 78,576 cerebral angiographies and 4,929 selective embolizations were performed. The average travel time to an SAH-capable hospital was 13.6 minutes, with 97% of the population within a 60-minute reach. A significant correlation was found between geographic accessibility and socioeconomic deprivation, with more deprived areas experiencing longer travel times. This cross-sectional study highlights disparities in access to aneurysmal SAH care across Germany. The findings demonstrate that while most of the population lives within a 60-minute travel time to appropriate hospitals, individuals in socioeconomically deprived areas face longer travel times and potentially reduced access to timely, specialized care. Given the high prehospital mortality associated with SAH, these accessibility gaps may contribute to worse outcomes in disadvantaged regions. To improve equity in emergency neurosurgical care, targeted political and structural interventions are required - especially for underserved populations in geographically and socioeconomically isolated areas.
Indexed as
Identifiers
40828346What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.